Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Predictive models for hepatocellular carcinoma development after sustained virological response in advanced hepatitis C
Miguel Fraile-López; Carmen Alvarez-Navascués; María Luisa González-Diéguez; Valle Cadahía; Valentina Chiminazzo; Andrés Castaño; María Varela; Manuel Rodríguez;
Gastroenterol Hepatol. 2023;46:754-63
Evaluation of the clinical and economic value of sofosbuvir/velpatasvir (SOF/VEL) in patients with chronic hepatitis C in Spain during the last 5 years
Rafael Esteban; Raquel Domínguez-Hernández; Helena Cantero; Miguel Ángel Casado;
Gastroenterol Hepatol. 2024;47:
Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy
Joan Martínez-Campreciós; Mar Riveiro-Barciela; Raquel Muñoz-Gómez; María-Carlota Londoño; Mercé Roget; Miguel Ángel Serra; Desamparados Escudero-García; Laura Purchades; Manuel Rodríguez; Juan E. Losa-García; María L. Gutiérrez; Isabel Carmona; Javier García-Samaniego; Luís Morano; Ignacio Martín-Granizo; Marta Montero-Alonso; Martín Prieto; Manuel Delgado; Natalia Ramos; María A. Azancot; Francisco Rodríguez-Frías; Maria Buti;
Gastroenterol Hepatol. 2023;46:594-602